Skip to main content
. 2014 Aug 25;20(6):905–911. doi: 10.1111/hae.12494

Figure 3.

Figure 3

Thrombin Generation Assay (Endogenous Thrombin Potential [ETP], peak thrombin and velocity) performed on FVIII concentrate samples in the presence of antibody anti-C2 (ESH-8), with or without VWF added (pdFVIII/VWF: plasma-derived FVIII/VWF complex; pdFVIII: plasma-derived FVIII; rFVIII: full-length recombinant FVIII; BDD-rFVIII: B-domain deleted recombinant FVIII) (n = 4–6); *P < 0.01 with respect to the value of the product without inhibitor (100%).